Dr Clive Ballard just now! | ACAD Message Board Posts

ACADIA Pharmaceuticals Inc.

  ACAD website

ACAD   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  15691 of 16165  at  9/19/2019 3:34:30 PM  by

longusa


 In response to msg 15690 by  ProSource
view thread

Re: Dr Clive Ballard just now!

ADP is part of the DRP indication.  ACAD said in the conf call that ~67% of the DRP PhIII enrollees were ADP diagnosis.
 
From the PR:

About the HARMONY Study

HARMONY is a Phase 3 study designed to evaluate the efficacy and safety of pimavanserin for the treatment of delusions and hallucinations associated with dementia-related psychosis across a broad population of patients with the most common subtypes of dementia including: Alzheimer’s disease, dementia with Lewy bodies, Parkinson’s disease dementia, vascular dementia, and frontotemporal dementia spectrum disorders.

 
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 6     Views: 403
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
15692 Re: Dr Clive Ballard just now! Nazaretti 1 9/19/2019 4:28:31 PM






About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...